Read + Share
Amedeo Smart
Independent Medical Education
Rousselot P, Mollica L, Guilhot J, Guerci A, et al. Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients. Br J Haematol 2021;194:393-402.PMID: 34195988
Email
LinkedIn
Facebook
Twitter
Privacy Policy